The coronavirus disease 2019 (COVID-19) pandemic likely affected youth with type 1 diabetes (T1D). We used electronic health record-extracted data to compare continuous glucose monitoring (CGM) metrics during 1 year of the pandemic with those of the previous year. The sample comprised CGM users, aged 1 to <18 years, with T1D duration ≥6 months (age <6 years) or ≥1 year (age ≥6 years). The prepandemic sample comprised 641 youth (52% female, aged 12.3 ± 3.5, T1D duration 6.0 ± 3.5 years). The pandemic sample comprised 648 youth (52% female, age 13.3 ± 3.5, duration 6.7 ± 3.8 years), with care delivered primarily through telemedicine. Mean CGM glucose was 6.3 mg/dL lower during the pandemic (187.3 ± 35.6) versus prepandemic (193.6 ± 33.0) (P < 0.001). A higher percentage of youth achieved glucose management indicator <7% during the pandemic than the prior year (P < 0.001). Lower CGM glucose values were observed during the COVID-19 pandemic. Future studies are needed to assess how changes in health care delivery, including telemedicine, and lifestyle during this time may have supported this improvement.

中文翻译：

---

在 COVID-19 大流行的 1 年期间，患有 1 型糖尿病的年轻人平均 CGM 葡萄糖的改善

2019 年冠状病毒病 (COVID-19) 大流行可能影响了患有 1 型糖尿病 (T1D) 的青少年。我们使用电子健康记录提取数据将大流行一年期间的连续血糖监测 (CGM) 指标与前一年的指标进行比较。样本包括 CGM 用户，年龄从 1 岁到 <18 岁，T1D 持续时间≥6 个月（年龄 <6 岁）或≥1 年（年龄≥6 岁）。大流行前样本包括 641 名青年（52% 为女性，年龄 12.3 ± 3.5，T1D 持续时间 6.0 ± 3.5 岁）。大流行样本包括 648 名青年（52% 为女性，年龄 13.3 ± 3.5 岁，持续时间 6.7 ± 3.8 岁），主要通过远程医疗提供护理。与大流行前 (193.6 ± 33.0) 相比，大流行期间 (187.3 ± 35.6) 的平均 CGM 葡萄糖降低了 6.3 mg/dL ( P < 0.001)。与前一年相比，大流行期间达到血糖管理指标 <7% 的青年比例更高（P  < 0.001）。在 COVID-19 大流行期间观察到较低的 CGM 葡萄糖值。未来的研究需要评估在此期间医疗保健服务（包括远程医疗）和生活方式的变化如何支持这种改善。